Literature DB >> 10893279

Discussing complementary therapies with cancer patients: what should we be talking about?

H J Burstein.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10893279     DOI： 10.1200/JCO.2000.18.13.2501

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Use of complementary and alternative medicine among men with prostate cancer in a rural setting.

Authors:  Susan Butler; Ashli Owen-Smith; Colleen DiIorio; Michael Goodman; Jonathan Liff; Kyle Steenland
Journal:  J Community Health       Date:  2011-12

Review 2.  Integrating complementary medicine in supportive cancer care models across four continents.

Authors:  Eran Ben-Arye; Elad Schiff; Catherine Zollman; Peter Heusser; Pablo Mountford; Moshe Frenkel; Gil Bar-Sela; Ofer Lavie
Journal:  Med Oncol       Date:  2013-02-23       Impact factor: 3.064

3.  Finding the words: literacy and traditional vietnamese medicine.

Authors:  Emily King
Journal:  Perm J       Date:  2007

4.  Teaching complementary medicine at an academic oncology department.

Authors:  Eran Ben-Arye; Moshe Frenkel; Gil Bar-Sela; Ruth Stashefsky Margalit; Doron Hermoni; Abraham Kuten
Journal:  J Cancer Educ       Date:  2008 Jan-Mar       Impact factor: 2.037

Review 5.  Complementary and alternative medicine (CAM) and supportive care in cancer: a synopsis of research perspectives and contributions by an interdisciplinary team.

Authors:  Anne Leis; Jennifer Millard
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

6.  Oncologists' experiences of discussing complementary and alternative treatment options with their cancer patients. A qualitative analysis.

Authors:  Güthlin Corina; Holmberg Christine; Gudrun Klein
Journal:  Support Care Cancer       Date:  2016-04-14       Impact factor: 3.603

7.  Development and Validation of an Instrument for Measuring Attitudes and Beliefs about Complementary and Alternative Medicine (CAM) Use among Cancer Patients.

Authors:  Jun J Mao; Steve C Palmer; Krupali Desai; Susan Q Li; Katrina Armstrong; Sharon X Xie
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-30       Impact factor: 2.629

8.  Use of complementary/alternative therapies by women with advanced-stage breast cancer.

Authors:  Joannie Shen; Ronald Andersen; Paul S Albert; Neil Wenger; John Glaspy; Melissa Cole; Paul Shekelle
Journal:  BMC Complement Altern Med       Date:  2002-08-13       Impact factor: 3.659
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.